OU Health announced a major expansion of cancer care in Tulsa at 41st and Yale. a move leaders said could bring hope to ...
Health and Me on MSN
Anktiva approved in Saudi Arabia as world’s first lung cancer therapy — all you need to know
Saudi Arabia approves Anktiva, an IL-15 immunotherapy, for bladder and lung cancer, marking its first regulatory clearance ...
Saudi Arabia leads the way as the first country to grant conditional approval for Anktiva, a groundbreaking treatment for ...
Despite 700% net product revenue growth to $113 million, ImmunityBio's high debt load and unprofitability remain significant ...
A new cancer therapy wakes up immune cells inside tumors and turns them against cancer.
ImmunityBio’s Anktiva receives Saudi FDA approval for non-muscle invasive bladder cancer with carcinoma in-situ: Culver City, California Friday, January 16, 2026, 15:00 Hrs [IST ...
According to the American Cancer Society, more than 2 million new cancer cases are estimated to have been diagnosed in the ...
Researchers found better detection, treatment and decreased smoking have been immensely helpful in reducing deaths due to ...
InvestorsHub on MSN
Theralase and Ferring ink deal for new bladder cancer study
Theralase Technologies (USOTC:TLTFF) signed a clinical development agreement with Ferring Pharmaceuticals, a top name in ...
Cancer survival rates climbed significantly in recent decades. But federal funding cuts could threaten that progress, ...
Relmada Therapeutics is a clinical-stage biotechnology company focused on developing transformative therapies for oncology ...
On track to report interim results from approximately 25 six-month evaluable BCG-Unresponsive patients in ADVANCED-2 trial in Q1 2026Received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback